GSK Buys Out Partner Neptunus' Stake in Chinese Vaccines Joint Venture
This article was originally published in The Pink Sheet Daily
Executive Summary
New Chinese Pharmacopoeia standards that mean increased development spending and longer timelines to launch may be at play.